Cooper Companies Inc (COO) was Upgraded by Jefferies to ” Buy”. Earlier the firm had a rating of “Hold ” on the company shares. Jefferies advised their investors in a research report released on Apr 15, 2016.
On the company’s financial health, Cooper Companies Inc reported $1.83 EPS for the quarter, beating the analyst consensus estimate by $ 0.25 according to the earnings call on Mar 3, 2016. Analyst had a consensus of $1.58. The company had revenue of $449.60 million for the quarter, compared to analysts expectations of $442.03 million. The company’s revenue was up 1.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.75 EPS.
Cooper Companies Inc closed down -0.26 points or -0.17% at $154.95 with 2,81,736 shares getting traded on Monday. Post opening the session at $155.4, the shares hit an intraday low of $153.55 and an intraday high of $155.89 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.
In a different news, on Mar 10, 2016, Gregory W Matz (SVP, CFO & CRO) sold 10,000 shares at $146.94 per share price. According to the SEC, on Oct 6, 2015, Allan E Rubenstein (director) sold 294 shares at $150.00 per share price. On Sep 8, 2015, Steven Rosenberg (director) sold 17,500 shares at $149.44 per share price, according to the Form-4 filing with the securities and exchange commission.
The Cooper Companies Inc. (Cooper) is a global medical device company. The Company operates through two business units CooperVision Inc. (CVI) and CooperSurgical Inc. (CSI). CooperVision is a global manufacturer providing products for contact lens wearers. CooperSurgical focuses on supplying women’s health clinicians with products and treatment options to improve the delivery of healthcare to women. CooperSurgical products fall into three main segments based on the point of healthcare delivery: Hospital Office and Fertility Clinic. CooperVision develops manufactures and markets a range of monthly two-week and single-use contact lenses featuring advanced materials and optics. CooperVision is involved in correcting vision problems such as astigmatism presbyopia and ocular dryness and provides innovative contact lens solutions. The CooperVision Companys brands include Biofinity Avaira and MyDay and CooperSurgical Companys brands include Advincula Arch SeeClear and Mobius.